Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Breast Lesion Localization Market Outlook (2022- 2032)

[309 Pages Report] The breast lesion localization market is expected to strengthen its hold on the global market at an average CAGR of 4.1% between 2022 and 2032. The market is valued at US$ 256 Mn in 2022 and is likely to reach US$ 382 Mn by 2032. Previously, the market was thriving at a slightly higher CAGR of 4.9% (2015-2021), ensuring a market size of US$ 244 Million in 2021.

“Rising cases of breast cancer led by increased government spending on the research and development of drugs and services to counter the disease are flourishing the breast lesbian localization market, enhancing the healthcare structure while spreading awareness about the early diagnosis.”

Monitoring and diagnosis of cancer gain a lot of market traction for the breast lesion localization market. The increased use of advanced healthcare tools and services is leading breast cancer detection easy and confined. With the help of breast lesion localization services, the processes of imaging, screening, and scanning become smooth and easy.

As the market grows in the regions where breast cancer is the most common cancer among a lot of regions, it is attributed to the growth of the breast lesion localization market.

Attributes Details
Breast Lesion Localization Market CAGR (2022-2032) 4.1%
Breast Lesion Localization Market Value (2022) US$ 256 Million
Breast Lesion localization Market Value (2032) US$ 382 Million

A global study on the Breast lesion localization market shows that the rising breast cancer cases in the region are the driving factor for the market, coupled with the growing awareness around the new technologies coming into the diagnostics and healthcare sector is increasing the sales of breast lesion localization services.

Breast cancer’s early detection and screening, and treatment, according to that diagnosis, have gained a good amount of traction in the breast lesion localization market. Breast cancer is the second leading cancer-related death in women worldwide. Integration of the latest diagnosis practices with cutting-edge healthcare also makes the screening process easy.

The chances of getting breast cancer increase with the growing age as a type of adult stem cell at the root cause of breast cancer. This directly affects the myoepithelial cells, which eventually line the breast’s milk-producing liminal cells and works as tumor suppressors.

American cancer society explains that one out of eight women gets breast cancer under 45 of age. Though the number differs for women who are older than 45 years of age, approximately 2 out of 3 women develop invasive breast cancer.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Is The COVID-19 Impact On The Breast Lesion Localization Market?

Breast lesion localization market analysis has focused on explaining how the advent of covid-19 has shaped various markets differently. It has adversely affected some markets, damaging the supply chains, nullifying the distribution channels, and pushing markets towards turmoil. However, it has also been beneficial for a set of markets, especially the healthcare and diagnostics market.

People have become more aware of their health and keep a check on their vitals and health conditions through multiple diagnosis processes. Breast cancer, being one of the most common cancers out there, needs breast lesion localization services. People diagnosed with breast cancer have higher chances of getting covid-19 as their immunity is already low.

Breast lesion localization involves early detection and screening of breast cancer so it can be cured as soon as possible. The lockdown and travel restrictions affected the market’s growth in the first quarter of the pandemic, but as soon as diagnostic services started functioning, the market came back on track with a healthy growth rate.

Other components of the market also grow parallel, like breast biopsy, shaping the trends of the breast lesion localization market. These fuels the sales of breast lesion localization services in new regions.

What Are The Key Dynamics Governing The Growth Of The Breast Lesion Localization Market?

“Rising chronic diseases like breast cancer and multiple diagnosis methods including early detection and screening coupled with it being the most prevalent cancer are helping the breast lesion localization market gain traction”

The government initiatives are working in order to spread awareness around breast cancer, diagnosis, symptoms, surgeries, and stages that help people in fighting against breast cancer.

Government programs also promote multiple kinds of diagnosis, treatment, and screening processes that help doctors and patients understand the real-time situation, pushing the demand for breast lesion localization. Another factor that creates multiple opportunities for the market is the high capital investments of emerging economies like India and China in their healthcare sector.

These countries are currently upgrading or building their healthcare structure, spending huge amounts on the development of the infrastructure. Countries also run programs to welcome the companies that provide a direct supply chain to healthcare and diagnostics services.

The shortage of oncologists is limiting the sales of breast lesion localization systems that perform by skilled professionals. The localization of tumors, lymphedema, seroma and risk of healthy tissue excision are some of the processes that breast lesion localization has.

Other reasons that restrict the market’s growth are the FDA approvals and the uncertainty attached to it. Players that operate the breast lesion localization need to obtain nuclear regulatory clearance to get listed among the registered operators. 

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View Of Adjacent Breast Lesion Localization Market

Breast lesion localization Market:

Attributes Breast lesion localization Market
CAGR (2022-2032) 4.1%
Market Value (2026) US$ 300.64 Billion
Growth Factor Rising cases of breast cancer, demand for technologically advanced diagnosis processes are increasing the sales of breast lesion localization platforms.
Opportunity The market creates opportunities for the diagnosis centres to use advanced technology that run on different checks and touchpoints, enhancing the accuracy.
Key Trends Platforms like artificial intelligence, machine learning and Internet of things (IOT) integrating with the breast lesion localization platforms are creating tons of opportunities for market.

Skin Cancer Diagnostics & Therapeutics Market:

Attributes Skin Cancer Diagnostics & Therapeutics Market
CAGR (2022-2032) 10%
Market Value (2026) US$ 10.7 Billion
Growth Factor Pollution and direct exposition to the UV rays is leading to the rising number of skin cancer patients in the various parts of the countries, pushing the skin cancer diagnostics & therapeutics market upward.
Opportunity New advanced versions and stages are a challenge that creates multiple opportunities for the skin cancer diagnostics & therapeutics market to experiment and diversify their approach.
Key Trends To get into multiple layers of symptoms, followed by the first line protocol while integrating with Artificial intelligence and machine learning.

Oncology Market:

Attributes Oncology Market
CAGR (2022-2032) 8%
Market Value (2026) US$ 360 Billion
Growth Factor Rising awareness regarding cancer and availability of various oncology treatments and innovative diagnostic tools, fueling the demand for oncology analysts.
Opportunity The market creates opportunities for the component markets like cancer diagnosis and therapeutic, helping them find their space in the market race.
Key Trends The machine learning and internet of things (IOT) integrate with oncology tools to make it easy and accurate are flourishing the trends of oncology market.

Global trends in breast lesion localization market are followed by the new technology integrating and making the monitoring and scanning process easy so that it can be treated with precision. The use of cutting-edge technology like artificial intelligence, integrated healthcare platforms, digital monitors have helped the healthcare and diagnosis sector to evolve and get set up in new regions.

The consumption of breast lesion localization is attributed to its better care and screening that help to give the best possible results. Operators work with new cutting-edge technology to make sure they don’t miss out on advanced cell movement phenomena, making breast lesion localization systems the platform that holds accuracy.

What Is The Segmentation Outlook For The Breast Lesion Localization Market?

The breast lesion localization market is categorized by type and usage. These categories are further divided into small segments that expand their channels in multiple market spaces. These segments perform differently in multiple markets as they have a stronghold in multiple regions.

The type category is segmented into wire localization, radioisotope localization, magnetic localization, and electromagnetic localization, while the usage category is divided into breast biopsy and breast conservation (Lumpectomy).  

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Which Segment Is Likely To Lead The Breast Lesion Localization Market By Usage?

By usage, the breast biopsy segment is the largest segment and will hold the biggest portion of the market in the forecast period. The analysis shows that the breast biopsy segment is set to thrive at a CAGR of 3.5% in the forecast period, while previously, the segment was thriving at a slightly higher CAGR of 4.0%.

Breast lesion localization market analysis explains that the factors behind the growth of this segment are its easy removal and short time span, and lower post-surgery impacts than the lumpectomy. Also, the breast biopsy can be used to remove an abnormality within the breast, while lumpectomy (Partial mastectomy) can only be used to remove breast cancer. These factors flourish the demand for breast lesion localization market.   

What Is The Regional Analysis For The Breast Lesion Localization Market?

The breast lesion localization market is divided into regions; North America, Latin America, Asia Pacific, Middle East and Africa (MEA), and Europe. The biggest market is the United States, which is flourishing at a CAGR of 3.9% between 2022-2032.

The region is likely to hold a market revenue of US$ 136.3 Mn by the end of 2032. Increasing breast cancer cases coupled with advanced diagnosis options while upgrading the healthcare system and their integration with the latest technology like AI and IOT are fueling the growth in this region.

The UK is the highest growing market globally and will hold US$ 18.2 Mn by the end of 2032 as it thrives on a promising CAGR of 4.4% between 2022-2032. Other regions like Asia pacific also flourished, with developing countries like China booming at a CAGR of 3.6% and Japan growing at a CAGR of 3.8%, while their projected values are US$ 28 Mn and US$ 25.2 Mn, respectively. 

Regions CAGR (2022-2032)
United States 3.9%
United Kingdom 4,4%
China 3.6%
Japan 3.8%
South Korea 3.0%
  • The US holds the biggest portion in the breast lesion localization market.   
  • UK is the highest growing market in the breast lesion localization market with a CAGR of 4.4% through 2032.   
  • Rising breast cancer patients, growing population of old women who are more exposed to the breast cancer and advanced healthcare technology are owing to the increased sales of breast lesion localization platforms.   

How Is The Competition In The Breast Lesion Localization Market?

The competitive landscape of breast lesion localization is dynamic in nature and allows new competitors to thrive in the market and increase competitiveness. The companies in the market are a part of mergers and collaborations that result in increased distribution channels and market spaces. These companies focus on updating the price ranges, while making the platforms more patient friendly.   

Recent Developments in the Breast Lesion Localization Market:

  • Hologic Inc has introduced LOCalizer, the wire-free breast lesion system that is designed to mark and guide non-palpable breast lesions using a miniature. This innovative technology pushes the market and increases the demand for breast lesion localization processes.
  • Merit Oncology has upgraded its scout radar localization that helps in reducing the OR delays and targets the affected tissue and points it out, easing the surgery processes.

Key Players

Key Segments

By Type:

  • Wire Localization
  • Radioisotope Localization
  • Magnetic Localization
  • Electromagnetic Localization

By Usage:

  • Breast Biopsy
  • Breast Conservation (Lumpectomy) 

By Region:

  • United States
  • United Kingdom
  • China
  • Japan
  • South Korea

Frequently Asked Questions

What is the CAGR of the Breast Lesion Localization Market?

The breast lesion localization market is set to grow at a CAGR of 4.1% through 2032.

Which is the Biggest Region in the Breast Lesion Localization Market?

North America is the biggest region in breast lesion localization market that is flourishing at at a CAGR of 3.5 by 2032.

Which Segment leads in the Breast Lesion Localization Market by Product usage?

Breast Biopsy is the leading segment in the breast lesion localization market by usage, thriving at a CAGR of 3.5% through 2032.

Which Region has the Highest Growth Potential?

United Kingdom has the highest growth potential in the breast lesion localization market, thriving at CAGRs of 3.5% through 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Breast Lesion Localization Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

    4.1. Global Protective Coatings Market (US$ Mn)

    4.2. Breast Lesion Localization Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Protective Coatings Market Growth

        4.5.3. Breast Lesion Localization Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Breast Lesion Localization Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Breast Lesion Localization Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Breast Lesion Localization Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032

        8.3.1. Wire Localization

        8.3.2. Radioisotope Localization

        8.3.3. Magnetic Localization

        8.3.4. Electromagnetic Localization

        8.3.5. Other Localization Methods

    8.4. Market Attractiveness Analysis By Type

9. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Usage

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Usage, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2022-2032

        9.3.1. Breast Biopsy

        9.3.2. Breast Conservation (Lumpectomy)

    9.4. Market Attractiveness Analysis By Usage

10. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific

        10.3.5. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. U.S.

            11.4.1.2. Canada

            11.4.1.3. Rest of North America

        11.4.2. By Type

        11.4.3. By Usage

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Type

        11.5.3. By Usage

12. Latin America Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Brazil

            12.4.1.2. Mexico

            12.4.1.3. Rest of Latin America

        12.4.2. By Type

        12.4.3. By Usage

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Type

        12.5.3. By Usage

13. Europe Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Germany

            13.4.1.2. France

            13.4.1.3. U.K.

            13.4.1.4. Italy

            13.4.1.5. Benelux

            13.4.1.6. Nordic Countries

            13.4.1.7. Rest of Europe

        13.4.2. By Type

        13.4.3. By Usage

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Type

        13.5.3. By Usage

14. Asia Pacific Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. China

            14.4.1.2. Japan

            14.4.1.3. South Korea

            14.4.1.4. Rest of Asia Pacific

        14.4.2. By Type

        14.4.3. By Usage

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Type

        14.5.3. By Usage

15. Middle East and Africa Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. GCC Countries

            15.4.1.2. South Africa

            15.4.1.3. Turkey

            15.4.1.4. Rest of Middle East and Africa

        15.4.2. By Type

        15.4.3. By Usage

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Type

        15.5.3. By Usage

16. Key Countries Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

        16.1.1. Market Value Proportion Analysis, By Key Countries

        16.1.2. Global Vs. Country Growth Comparison

    16.2. US Breast Lesion Localization Market Analysis

        16.2.1. Value Proportion Analysis by Market Taxonomy

        16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.2.2.1. By Type

            16.2.2.2. By Usage

    16.3. Canada Breast Lesion Localization Market Analysis

        16.3.1. Value Proportion Analysis by Market Taxonomy

        16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.3.2.1. By Type

            16.3.2.2. By Usage

    16.4. Mexico Breast Lesion Localization Market Analysis

        16.4.1. Value Proportion Analysis by Market Taxonomy

        16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.4.2.1. By Type

            16.4.2.2. By Usage

    16.5. Brazil Breast Lesion Localization Market Analysis

        16.5.1. Value Proportion Analysis by Market Taxonomy

        16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.5.2.1. By Type

            16.5.2.2. By Usage

    16.6. Germany Breast Lesion Localization Market Analysis

        16.6.1. Value Proportion Analysis by Market Taxonomy

        16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.6.2.1. By Type

            16.6.2.2. By Usage

    16.7. France Breast Lesion Localization Market Analysis

        16.7.1. Value Proportion Analysis by Market Taxonomy

        16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.7.2.1. By Type

            16.7.2.2. By Usage

    16.8. Italy Breast Lesion Localization Market Analysis

        16.8.1. Value Proportion Analysis by Market Taxonomy

        16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.8.2.1. By Type

            16.8.2.2. By Usage

    16.9. BENELUX Breast Lesion Localization Market Analysis

        16.9.1. Value Proportion Analysis by Market Taxonomy

        16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.9.2.1. By Type

            16.9.2.2. By Usage

    16.10. UK Breast Lesion Localization Market Analysis

        16.10.1. Value Proportion Analysis by Market Taxonomy

        16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.10.2.1. By Type

            16.10.2.2. By Usage

    16.11. Nordic Countries Breast Lesion Localization Market Analysis

        16.11.1. Value Proportion Analysis by Market Taxonomy

        16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.11.2.1. By Type

            16.11.2.2. By Usage

    16.12. China Breast Lesion Localization Market Analysis

        16.12.1. Value Proportion Analysis by Market Taxonomy

        16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.12.2.1. By Type

            16.12.2.2. By Usage

    16.13. Japan Breast Lesion Localization Market Analysis

        16.13.1. Value Proportion Analysis by Market Taxonomy

        16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.13.2.1. By Type

            16.13.2.2. By Usage

    16.14. South Korea Breast Lesion Localization Market Analysis

        16.14.1. Value Proportion Analysis by Market Taxonomy

        16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.14.2.1. By Type

            16.14.2.2. By Usage

    16.15. GCC Countries Breast Lesion Localization Market Analysis

        16.15.1. Value Proportion Analysis by Market Taxonomy

        16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.15.2.1. By Type

            16.15.2.2. By Usage

    16.16. South Africa Breast Lesion Localization Market Analysis

        16.16.1. Value Proportion Analysis by Market Taxonomy

        16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.16.2.1. By Type

            16.16.2.2. By Usage

    16.17. Turkey Breast Lesion Localization Market Analysis

        16.17.1. Value Proportion Analysis by Market Taxonomy

        16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            16.17.2.1. By Type

            16.17.2.2. By Usage

        16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

    17.1. Market Analysis by Tier of Companies

    17.2. Market Concentration

    17.3. Market Share Analysis of Top Players

    17.4. Market Presence Analysis

        17.4.1. By Regional footprint of Players

        17.4.2. Product footprint by Players

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Competition Deep Dive

        18.3.1. Hologic, Inc.

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio

            18.3.1.3. Sales Footprint

            18.3.1.4. Strategy Overview

        18.3.2. Becton, Dickinson and Company

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio

            18.3.2.3. Sales Footprint

            18.3.2.4. Strategy Overview

        18.3.3. Merit Medical Systems

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio

            18.3.3.3. Sales Footprint

            18.3.3.4. Strategy Overview

        18.3.4. Leica Biosystems Nussloch GmbH

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio

            18.3.4.3. Sales Footprint

            18.3.4.4. Strategy Overview

        18.3.5. Argon Medical Devices

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio

            18.3.5.3. Sales Footprint

            18.3.5.4. Strategy Overview

        18.3.6. Laurane Medical LLC

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio

            18.3.6.3. Sales Footprint

            18.3.6.4. Strategy Overview

        18.3.7. Endomagnetics Ltd.

            18.3.7.1. Overview

            18.3.7.2. Product Portfolio

            18.3.7.3. Sales Footprint

            18.3.7.4. Strategy Overview

        18.3.8. Intramedical Imaging, LLC

            18.3.8.1. Overview

            18.3.8.2. Product Portfolio

            18.3.8.3. Sales Footprint

            18.3.8.4. Strategy Overview

        18.3.9. Isoaid

            18.3.9.1. Overview

            18.3.9.2. Product Portfolio

            18.3.9.3. Sales Footprint

            18.3.9.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Digital Breast Tomosynthesis (DBT) Equipment Market

Published : September 2023

Healthcare

Molecular Breast Imaging Market

Published : August 2023

Healthcare

Automated Breast Ultrasound Systems Market

Published : June 2023

Healthcare

Breast Lesion Localization Market

Published : May 2022

Explore Healthcare Insights

View Reports

Breast Lesion Localization Market